Itaconix PLC Appointment: Nominated Adviser and Sole Broker

RNS Number : 9812A

Itaconix PLC

26 January 2024

 

  Itaconix plc

("Itaconix" or the "Company")

Appointment of Nominated Adviser and Sole Broker

 

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used to decarbonise everyday consumer products, is pleased to announce that it has appointed Canaccord Genuity Limited as its Nominated Advisor and Sole Broker, with immediate effect.

 

In addition to the disclosures made in Paul LeBlanc's appointment announcement on 5 January 2023, the following current directorships are disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies:

 

Company	Supporting Information
Safe Reflections International Holdings LLC	A subsidiary of Bemis Associates Inc. directorship held at the time of appointment to Itaconix
Protechnic S.A.	A subsidiary of Bemis Associates Inc. directorship held at the time of appointment to Itaconix

 

 

Itaconix plc	[phone]
John R. Shaw / Laura Denner
Belvedere Communications	[phone]
John West / Llew Angus
Canaccord Genuity - Nominated Adviser and Sole Broker Adam James / Harry Pardoe	[phone]

 

About Itaconix  

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products.  The Company's current ingredients are enabling and leading new generations of products in cleaning, hygiene, and beauty.   

www.itaconix.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

APPPPUUPGUPCPUA